from Florida Atlantic University
There’s a new carb in town! This one is short for carbamathione, a new and promising treatment for the most common type of stroke. Dr. John Wu of Florida Atlantic University has received a patent for his discovery, which has already proved safe in protecting brain tissue from injury following a stroke. He says once it has proved effective in clinical trials, Carb can be used on patients. A pharmaceutically formulated version of carbamathione could be given as an injection to treat patients diagnosed with ischemic stroke up to twenty-four hours after onset of a stroke. The current best treatment for this type of stroke, tissue plasminogen activator or TPa, must be given in the first four hours.